Phospho-PDGFRA (Y762) Antibody

What is Phospho-PDGFRA (Y762) Antibody and what does it detect?

Phospho-PDGFRA (Y762) Antibody specifically detects endogenous levels of PDGF Receptor alpha only when phosphorylated at tyrosine 762. This antibody recognizes the phosphorylated form of the receptor, which is important for studying PDGFRA signaling pathways . The Y762 site is located in the activation loop of the PDGFRα kinase domain, making this antibody valuable for studying receptor activation mechanisms .

What are the common applications for Phospho-PDGFRA (Y762) Antibody?

Phospho-PDGFRA (Y762) Antibody has been validated for multiple applications:

These applications enable researchers to detect phosphorylated PDGFRA in various experimental contexts .

What species reactivity is expected for Phospho-PDGFRA (Y762) Antibody?

While reactivity varies by manufacturer, most Phospho-PDGFRA (Y762) antibodies react with:

• Human (validated across multiple manufacturers)

• Mouse (validated for some antibodies)

• Rat (validated for some antibodies)

Some manufacturers also predict reactivity with pig, bovine, horse, sheep, dog, chicken, and Xenopus based on sequence homology, though these applications require validation .

How should Phospho-PDGFRA (Y762) Antibody be stored and handled?

For optimal performance:

• Store lyophilized antibody at -20°C to -70°C for up to 12 months from receipt

• After reconstitution in sterile PBS, store at:

  • 2-8°C for up to 1 month under sterile conditions

  • -20°C to -70°C for up to 6 months under sterile conditions

• Avoid repeated freeze-thaw cycles

• Some formulations contain 50% glycerol, 0.5% BSA, and 0.02% sodium azide

What is the recommended protocol for Western Blot using Phospho-PDGFRA (Y762) Antibody?

For optimal Western Blot results:

• Prepare cell lysates from cells treated with appropriate stimuli (e.g., 100 ng/mL PDGF-AA or PDGF-BB for 10 minutes)

• Run samples on SDS-PAGE and transfer to PVDF membrane

• Block membrane according to standard protocols

• Incubate with Phospho-PDGFRA (Y762) Antibody at 0.5 μg/mL dilution overnight at 4°C

• Wash and incubate with appropriate HRP-conjugated secondary antibody

• Develop using chemiluminescence detection system

• Expected molecular weight: approximately 180-190 kDa

This protocol has been validated to detect specific phosphorylation of PDGFRA at Y762 following growth factor stimulation .

How should samples be prepared for optimal phospho-PDGFRA detection?

For maximum phosphorylation signal detection:

• Treat cells with PDGF-AA or PDGF-BB (100 ng/mL) for 10 minutes to induce receptor phosphorylation

• Immediately lyse cells in buffer containing phosphatase inhibitors (critical)

• For tissue samples, flash-freeze and homogenize rapidly in lysis buffer with phosphatase inhibitors

• Maintain samples at cold temperatures throughout processing

• For immunohistochemistry, use freshly fixed tissues and perform antigen retrieval

Phosphorylation status is sensitive to sample handling, making proper preparation essential for accurate results .

What controls should be included when using Phospho-PDGFRA (Y762) Antibody?

Recommended controls include:

• Positive control: Human foreskin fibroblasts treated with PDGF-AA or PDGF-BB

• Negative control: Untreated cells expressing PDGFRA

• Specificity control: Pretreatment with phosphatase

• Blocking peptide control: When available, use the phosphopeptide immunogen to confirm specificity

• Antibody isotype control: Use matched isotype antibody to rule out non-specific binding

What is the significance of Y762 phosphorylation in PDGFRA signaling?

Phosphorylation at Y762 plays several critical roles:

• Located in the activation loop of the PDGFRα kinase domain

• Serves as a docking site for adaptor proteins CrkII and CrkL following growth factor stimulation

• Contributes to downstream signaling cascades including cell proliferation and migration

• May have differential effects depending on the activating ligand (PDGF-AA vs. PDGF-BB)

Understanding this specific phosphorylation event provides insights into the regulation of PDGFRA-mediated cellular responses .

How can Phospho-PDGFRA (Y762) Antibody be used in Proximity Ligation Assay?

For in situ Proximity Ligation Assay (PLA):

• Use dual recognition antibody pair: rabbit polyclonal anti-Phospho-PDGFRA (Y762) and mouse monoclonal anti-PDGFRA

• Dilute rabbit antibody at 1:1200 and mouse antibody at 1:50

• Follow standard PLA protocol with appropriate PLA probes

• Each red dot in the resulting images represents a single phosphorylated protein

• Analyze images using specialized software (e.g., BlobFinder)

This technique allows visualization and quantification of individual phosphorylation events within cells at endogenous expression levels .

How does phosphorylation at Y762 compare with other PDGFRA phosphorylation sites?

PDGFRA contains multiple tyrosine phosphorylation sites with distinct functions:

Y762 phosphorylation should be studied in context with these other sites to fully understand PDGFRA signaling complexity .

What methodological approaches can distinguish between PDGFRA homodimers and PDGFRA/PDGFRB heterodimers?

To distinguish between receptor dimer configurations:

• Sequential immunoprecipitation:

  • First IP with Phospho-PDGFRA (Y762) Antibody

  • Western blot for PDGFRB in the precipitate

• Proximity ligation assay:

  • Use anti-Phospho-PDGFRA (Y762) with anti-PDGFRB antibodies

  • Positive signals indicate heterodimer formation

• FRET or BRET analysis:

  • Tag receptors with appropriate fluorophores

  • Measure energy transfer upon dimerization

This distinction is important as PDGFRA forms both homodimers and heterodimers with PDGFRB, each potentially activating different signaling pathways .

What are common causes of weak or absent signal when using Phospho-PDGFRA (Y762) Antibody?

Several factors can cause weak signals:

• Insufficient phosphorylation:

  • Verify stimulation conditions (time, concentration)

  • Ensure phosphatase inhibitors are present in lysis buffer

  • Consider using pervanadate treatment as positive control

• Technical issues:

  • Antibody concentration too low (increase concentration)

  • Insufficient antigen retrieval for IHC

  • Protein degradation during sample preparation

  • Secondary antibody mismatch

• Biological factors:

  • Low expression of PDGFRA in sample

  • Rapid dephosphorylation during processing

How can specificity of Phospho-PDGFRA (Y762) Antibody be validated?

To confirm antibody specificity:

• Phosphatase treatment:

  • Treat one sample with lambda phosphatase

  • Signal should disappear if antibody is phospho-specific

• Peptide competition:

  • Pre-incubate antibody with phospho-peptide immunogen

  • Specific signal should be blocked

• Genetic approaches:

  • Use PDGFRA knockout/knockdown cells

  • Use PDGFRA Y762F mutant expressing cells

• Stimulation experiments:

  • Compare unstimulated vs. PDGF-stimulated samples

  • Phospho-signal should increase with stimulation

How can the Phospho-PDGFRA (Y762) Antibody signal be enhanced for challenging samples?

For enhanced detection in difficult samples:

• Signal amplification systems:

  • Tyramide signal amplification (TSA)

  • Polymer-based detection systems

  • Biotin-streptavidin amplification

• Sample enrichment:

  • Immunoprecipitate PDGFRA first, then blot with phospho-antibody

  • Use phosphotyrosine enrichment before Western blotting

• Enhanced stimulation:

  • Combine PDGF with phosphatase inhibitors

  • Use higher concentrations of growth factors

  • Optimize stimulation time course

How can Phospho-PDGFRA (Y762) antibodies be used to study cancer biology?

For cancer research applications:

• Patient-derived xenograft (PDX) models:

  • Monitor PDGFRA Y762 phosphorylation status in response to targeted therapies

  • Correlate with tumor growth and metastasis

• Clinical specimen analysis:

  • Compare phosphorylation levels between normal and tumor tissues

  • Correlate with patient outcomes and treatment responses

• Drug screening:

  • Evaluate the effects of kinase inhibitors on Y762 phosphorylation

  • Use as a biomarker for drug efficacy in PDGFRA-dependent tumors

Evidence suggests that aberrant PDGFRA signaling contributes to various cancers, making phosphorylation status a valuable research target .

What insights can be gained from studying Y762 phosphorylation in developmental biology?

PDGFRA Y762 phosphorylation in development:

• Embryonic tissue analysis:

  • Track temporal and spatial phosphorylation patterns during development

  • Correlate with cell differentiation and tissue morphogenesis

• Stem cell differentiation:

  • Monitor phosphorylation during mesenchymal stem cell differentiation

  • Link to lineage commitment decisions

• Conditional knockout models:

  • Compare wild-type vs. Y762F mutant PDGFRA knock-in models

  • Assess developmental consequences of disrupted signaling

PDGFRA plays crucial roles in skeleton growth and cephalic closure during embryonic development, making phosphorylation status an important research focus .

What methodological considerations are important when using Phospho-PDGFRA (Y762) Antibody in high-throughput screening?

For high-throughput applications:

• Assay miniaturization:

  • Optimize antibody concentration for 384/1536-well formats

  • Validate signal:noise ratio in miniaturized format

• Automation compatibility:

  • Ensure protocols are compatible with liquid handling systems

  • Validate reproducibility across plate positions

• Data normalization:

  • Include appropriate controls for plate-to-plate variation

  • Develop robust Z'-factor for assay quality control

• Multiplexing considerations:

  • Validate antibody performance in multiplex assays

  • Ensure no cross-reactivity with other detection reagents